Stock Analiz

Arrowhead Pharmaceuticals, Inc. (ARWR) stock forecast and price target

Price $47.78 · data as of November 13, 2026

12-month price target

Average target$106.07
Upside / downside+122.0%
Analysts14
ConsensusStrong buy
Low $73.00Average $106.07High $126.00

Gold marker: average target · white marker: today’s price ($47.78)

Analyst ratings

Strong buy 4Buy 10Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends September 30, 2027
$-5.52−52.9%$266M
Next fiscal year
ends September 30, 2028
$-3.26+41.0%$492M
Next quarter
ends December 31, 2026
$-1.86−945.4%$36M
Quarter after
ends March 31, 2027
$-1.52−63.0%$62M

Consensus of the analysts covering Arrowhead Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 6 lowered.

Frequently asked questions

What is the Arrowhead Pharmaceuticals stock price target?

The average 12-month target from 14 analysts is $106.07, 122.0% above the current price of $47.78 Targets range from $73.00 to $126.00.

Is Arrowhead Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (4 strong buy, 10 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Arrowhead Pharmaceuticals expected to earn?

Analysts expect EPS of $-5.52 for the fiscal year ending September 30, 2027 and $-3.26 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.